Quantcast

Industry news that matters to you.  Learn more

NIH to Fund Studies on the Clinical Utility of Extracellular RNA for Biomarker Development

The National Institutes of Health announced last week that the National Institute of Neurological Disorders and Stroke (NINDS) on behalf of the NIH Common Fund Program on Extracellular RNA Communication will support studies that promote the identification and validation of extracellular RNA (exRNA)-based biomarkers readily available from human body fluids and to facilitate the assessment and qualification of biomarkers for their utility in the clinical setting.

New Salimetrics Salivary IL-1 Beta Immunoassay Kit

Salimetrics has completed development of an immunoassay kit that is fully validated for the measurement of interleukin-1 beta (IL-1 beta) in saliva samples.

NYU College of Dentistry Receives Grant to Identify Biomarkers for the Progression of Periodontal Disease

NYU College of Dentistry has been selected as one of five institutions that are sharing a $20.7 million grant from the National Institute of Dental and Craniofacial Research (NIH) to the Forsyth Institute to find new ways to diagnose and fight periodontal disease. As the recipient of a $1.8 million subcontract, the NYU College of Dentistry will screen research subjects and collect biological samples that will contribute to the overall project, “Biomarkers of Periodontal Disease Progression.”

Salimetrics Unveils New Website

Salimetrics has completed a research friendly redesign of their company website http://www.salimetrics.com, which will improve access to information on Salimetrics’ immunoassay kits, saliva collection products, and saliva testing services. In addition, the new website offers comprehensive advice on the best methods to collect, handle, store, and ship saliva samples for biomarker analysis, along with access to white papers and references to scientific research articles involving salivary analytes.

SciClips Launches Cancer Biomarker Database

The success of personalized cancer therapeutics relies on the development of companion diagnostic assays that can identify the most appropriate cancer patient, tumor type and disease state. To address this need, SciClips, a Wisconsin-based open innovation platform company that enables scientists and researchers to collaborate and share research and ideas, recently launched a cancer (oncology) biomarker database.